Charlotte Vernhes | Director Scientific and Medical Affairs
Vaccines Europe
Charlotte Vernhes is a bioengineer with 15 years of experience in vaccine research and development, spanning immunogenicity assessment, translational science, innovation management and public-private partnerships. Charlotte has played a pivotal role in European initiatives on RSV, where she focused on fostering broad stakeholder collaboration and raising RSV disease awareness. Currently serving as Director of Scientific and Medical Affairs at Vaccines Europe, she leads strategic initiatives to foster collaboration between industry, scientific communities, and policymakers, to advance vaccine innovation and science-driven policy.
Appearances:
Day 1 (20th October) @ 09:00
The Technology Revolution: Agility for the Wave of Next Generation Vaccines
- What new vaccines are on the horizon and what are our key scientific leaders championing?
- How close are we to precision immunology? What is the roadmap for platform vaccines in oncology, autoimmune disorders, and infectious diseases?
- What are the key performance and logistical benefits of advanced platforms (e.g. RNA) compared to traditional vaccine approaches?
- Which platform technologies are most likely to cut response timelines and deliver on the 100-day mission?
- How are regulatory agencies adapting their approval pathways to novel vaccines, new antigens and using AI in vaccine R&D and manufacturing?
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events